Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| SARC | rs62075875 | chr17:76516438 | G/C | 9.31E-5 | 250 | 33.17 | 29.37 | 15.57 | KM Plot |
| SARC | rs62076505 | chr17:45497439 | A/G | 9.98E-5 | 257 | 19.97 | 34 | 32.4 | KM Plot |
| SARC | rs62097055 | chr18:71820020 | A/C | 1.11E-5 | 254 | 32.4 | 28.28 | 6.43 | KM Plot |
| SARC | rs62097056 | chr18:71820112 | T/C | 5.28E-5 | 256 | 31.57 | 32.13 | 6.43 | KM Plot |
| SARC | rs62289166 | chr4:6969163 | A/G | 8.62E-5 | 251 | 32.5 | 30.77 | 12.82 | KM Plot |
| SARC | rs62297086 | chr4:909040 | G/A | 4.66E-6 | 248 | 34.02 | 36.67 | 15.93 | KM Plot |
| SARC | rs62330018 | chr5:309691 | C/T | 3.21E-5 | 252 | 33.47 | 28.33 | 9.47 | KM Plot |
| SARC | rs62462979 | chr7:134019379 | G/T | 2.02E-5 | 251 | 32.35 | 31.42 | 22.03 | KM Plot |
| SARC | rs6433387 | chr2:173888256 | C/G | 0 | 258 | 1.07 | 20.45 | 33.17 | KM Plot |
| SARC | rs6446559 | chr4:7011186 | G/A | 5.2E-5 | 250 | 12.82 | 30.77 | 32.6 | KM Plot |
| SARC | rs6464635 | chr7:144688017 | C/T | 2.93E-14 | 258 | 1.17 | 25.6 | 32.35 | KM Plot |
| SARC | rs647986 | chr1:182454717 | T/C | 1.86E-7 | 256 | 31.1 | 35.13 | 6.72 | KM Plot |
| SARC | rs6495535 | chr15:81247455 | C/T | 1.92E-5 | 253 | 32.3 | 30.25 | 7.82 | KM Plot |
| SARC | rs6500619 | chr16:4643452 | G/A | 3.86E-5 | 253 | 17.25 | 36.4 | 30.75 | KM Plot |
| SARC | rs6502911 | chr17:6029947 | C/T | 0 | 258 | 31.57 | 34.08 | 1.07 | KM Plot |